What do I need to do to turn on the yahoo Abbvie Message board button. All of my other stock message board buttons are turned on except Abbvie. Abbvie I must go in and key in yahoo Abbvie Message board in order to get to the board. Thanks in advance for any helpful info.
The 2014 year end balance for Alere looks like it needs a good cleaning and looks like a couple billion of debt also goes along with the purchase. Once they get the balance sheet cleaned up it looks like it will be a good deal for Abbott. All cash deal no shareholder dilution.
If Pfizer recalls all the outstanding shares in the old Pfizer and issues new shares in the new Pfizer will this trigger a capital gain taxing event for the exiting Pfizer shareholders? It would have if the Abbvie inversion deal had gone forward.
Gene, I too have had the Abbv message board grayed out and I have had no correspondence with yahoo. It happened quite some time ago and do not know why.
Five year plan, Good presentation of their pipeline, Guidance and Humira patent protections are more than likely having a larger impact than the Dividend. Do not get me wrong, the dividend is also a big plus.
It looks like Some Doctors were using the Abbvie products for a use that it was not recommended.
FT was the media that started the rumor not CNBC. CNBC reported that Abbott denied the buyout.
I think the investor disappointment was more on the international performance in the second quarter for Humira than it was on Hep C.
As A Abbott Shareholder I would be disappointed if Abbott showed their hand before all the bids are in and the best offer is presented.
Mylan is buying PRGO, not Abt. Abt just happens to be the largest shareholder of Mylan and Abt agrees with Mylan's purchase of PRGO.
Investors should understand in detail a company's operating structures and how those structures can affect there P&L. Abbott is a highly diversified company with manufacturing, R&D and SG&A operations located in areas of point of sale. With geographical operation costs lined with geographical revenue there is a lot less impact due to currency fluctuation on the bottom line (EPS) along with good currency hedge programs.
If you are referring to the trailing 12 months PE's than you must adjust out the ABBV breakup fee for a comparison. Best to look at this year PE for both companies. Gilead 10, ABBV 12.
Your are right. The low information investors do not know the science behind Pharmacyclics and ABT199 and other drug combos. Nor do they understand the market entry strategy for these products. That is what happens when you are a short term thinker.